tv.qiagenbioinformatics.com
tv.qiagenbioinformatics.com
Watch tutorials, interviews and much more on our web based TV channel!
Author
tv.qiagenbioinformatics.com
Category
Podcast website
Latest episode
Jul 8, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Decoding neuropathies with TDP-43 and CRISPR 08.07.2026 46:36
Neurodegenerative disorders linked to protein dysfunction are difficult to study because of the complexity of the underlying molecular interactions. A great example is TAR DNA-binding protein 43 (TDP-43), found in diseases like amyotrophic lateral sclerosis (ALS), Parkinson's disease and several types of dementia. Today, researchers are still trying to answer how TDP-43's activity translates into...
QIAGEN Ingenuity Pathway Analysis (IPA) for grant writing and publications 02.07.2026 1:30:00
IPA is more than just an analysis program; it can also help you write grants and publications. With IPA, you gain access to biological insights backed by expert-curated findings and thousands of pre-analyzed multi-omics datasets. You will learn: - To interrogate, predict and interpret > Interrogate critical pathways, predict regulators causing your observed expression changes...
AI meets expertise: A hybrid workflow for modern target ID 02.07.2026 46:08
AI excels at identifying patterns and generating insights across large datasets, but its output quality depends heavily on its training data. Meanwhile, projects involve making critical decisions – decisions that require a nuanced understanding of biology, subject-matter expertise and experience that AI lacks. That’s where humans come in. Our fireside chat will explore a hybrid workflow that combi...
Expanding rare disease horizons Developing a diagnostic algorithm for... 02.07.2026 56:48
In the absence of genetic testing, is there a clear way forward with diagnosing and treating rare genetic diseases? A great challenge in rare disease research is finding enough affected individuals to create large cohorts. In addition to limited logistical or financial access to NGS, clinicians are often left to rely solely on observed symptoms. Unfortunately, clear guidelines on facilitating diag...
Target discovery in Alzheimer’s: Linking causal biology with CNS expression 02.07.2026 54:27
Public neuroscience datasets are abundant, but they prove difficult to translate into targets due to complexities with brain regions, cell types and more. Using Alzheimer’s disease as a case study, our webinar will explore how you can combine causal relationship evidence with deeply curated neurodegenerative and neuroinflammatory disease cohorts to prioritize targets relevant to the central nervou...
New Feature: Comparison bubble map in IPA Interpret 30.06.2026 59:31
The Spring 2026 release of IPA introduces the Comparison Analysis bubble map to IPA Interpret. This feature lets users compare multiple treatments, diseases, cell types and other experimental conditions in a single, customizable and interactive graphic. With support for up to 50 IPA Core Analyses, this bubble map also shows all scored entities – Upstream Regulators, Canonical Pathways and more – i...
Turn any 'omics dataset into actionable insights with QIAGEN IPA 24.06.2026 0:29
QIAGEN Ingenuity Pathway Analysis (IPA) is a tertiary analysis platform that: - Predicts the activity of pathways, diseases, genes and more - Validates your results against existing research - Interprets your ‘omics data into clear, action-oriented insights Ready to turn your ‘omics data into discoveries? See how you can leverage expert-curated, AI-augmented knowledge for actionable...
Turn any 'omics dataset into actionable insights with QIAGEN IPA 24.06.2026 0:57
QIAGEN Ingenuity Pathway Analysis (IPA) is a tertiary analysis platform that: - Predicts the activity of pathways, diseases, genes and more - Validates your results against existing research - Interprets your ‘omics data into clear, action-oriented insights Ready to turn your ‘omics data into discoveries? See how you can leverage expert-curated, AI-augmented knowledge for actionable...
Franklin by QIAGEN for Hereditary Cancer Variant Interpretation 18.06.2026 53:09
Accurate variant interpretation is critical in hereditary cancer genetics, but it’s often complex due to conflicting data and evolving clinical context. In this webinar, Molecular Geneticist Dr. Ana Krivokuca will lead a live, case-based demonstration using Franklin by QIAGEN, showing how the platform's structured workflows, ACMG criteria and integrated data can support confident, transparent inte...
Reduce Discovery Risk Using Comorbidity Data, Omics and Knowledge Graphs 09.06.2026 1:00:01
Comorbidity data can reveal unexpected and insightful connections between diseases. Understanding shared risks and underlying mechanisms are critical for informing patient care, yet these analyses often present significant challenges for researchers. Using a case study on the correlation between asthma and inflammatory bowel disease (IBD) in women, this webinar will demonstrate how comorbidity dat...
Identify drug target receptors and investigate their mechanism of action 07.06.2026 56:03
Biomedical KB-HD analysis in Neo4j enables researchers to explore complex relationships between drugs, targets and diseases using a comprehensive biomedical knowledge graph. Explore how to use this expert-curated data to identify promising disease biomarkers and examine their targets for various applications, using GLP-1, diabetes and Alzheimer’s disease as an example. You will learn: - To qu...
Influenza Strain Typing Made Easy with QIAGEN CLC Genomics Workbench 03.06.2026 46:00
Influenza is a highly contagious disease that affects humans and multiple animal hosts. Since influenza viruses are prone to major genetic changes, continuous research is critical for global public health, enabling scientists to anticipate and mitigate the impact of this rapidly evolving pathogen. Our webinar will show how you can analyze and interpret influenza virus sequencing data using QIAGEN...
Get Hands-on with Franklin + HGMD – May 28 (Spanish) 03.06.2026 1:32:57
Welcome to one of our exclusive, hands-on virtual workshops to explore Franklin + HGMD Professional — a powerful variant interpretation and reporting solution combining AI-driven workflows with expertly curated evidence. During this session, you’ll analyze a real-world case involving a 3-month-old patient with complex neuromuscular phenotypes. Using Franklin + HGMD, you’ll prio...
Get Hands-on with Franklin + HGMD – May 27 (Portuguese) 03.06.2026 1:44:36
Welcome to one of our exclusive, hands-on virtual workshops to explore Franklin + HGMD Professional — a powerful variant interpretation and reporting solution combining AI-driven workflows with expertly curated evidence. During this session, you’ll analyze a real-world case involving a 3-month-old patient with complex neuromuscular phenotypes. Using Franklin + HGMD, you’ll prio...
Exploration of deeply curated single-cell data with OmicSoft Explorer 03.06.2026 1:29:02
QIAGEN OmicSoft Explorer is your portal to thousands of deeply curated and integrated ‘omics datasets. In this hands-on workshop, we will explore projects with cell-level data and use it to investigate relevant studies, diseases or genes of interest using curated metadata terms. See how you can use OmicSoft Explorer by itself or with Ingenuity Pathway Analysis (IPA) to accelerate biological insigh...
Simplify bulk and single-cell ATAC-seq analysis with QIAGEN CLC Genomics... 03.06.2026 1:30:59
ATAC-seq is a powerful technique for assessing chromatin accessibility and identifying regulatory regions across the genome. From bulk ATAC-seq for population-level findings to single-cell ATAC-seq (scATAC-seq) to resolve chromatin accessibility at the individual cell level, these approaches lend deeper insights into gene regulation and cell state. QIAGEN CLC Genomics Workbench Premium provides re...
Multi-omics (metabolomics, proteomics, transcriptomics) analysis using QIAGEN... 03.06.2026 1:32:39
This 90-minute training session will show you how QIAGEN Ingenuity Pathway Analysis (IPA) helps visualize molecular intricacies and variations at multiple levels, such as transcriptome, proteome and metabolome. Through a series of brief technical vignettes, we will demonstrate how to: - Generate associations among molecular signatures obtained via integrating multi-omics data - Extract mechanisms...
Beyond enrichment Causal discovery powered by Neo4j & QIAGEN Discovery KB+ 29.05.2026 36:45
One click from your target gene to disease drivers, drug candidates and causal evidence. The Neo4j & QIAGEN solution transforms causal biomedical knowledge from QIAGEN Discovery KB+ into an interactive discovery surface. Learn how to query biomarkers, navigate causal networks and find drug repositioning candidates, provenance and natural language summaries included.
QIAGEN and NVIDIA collaboration to advance AI driven drug discovery 29.05.2026 10:23
NVIDIA and QIAGEN are collaborating to bring trustworthy, contextual AI to drug discovery. By integrating NVIDIA's accelerated computing and the BioNeMo platform with QIAGEN Digital Insights' manually curated biomedical knowledge graphs, cited in over 70,000 peer-reviewed publications; the collaboration aims to transform how disease mechanisms, therapeutic targets, and biomarkers are identified. U...
Predict activity of regulators and biological functions directly on... 27.05.2026 4:59
Single cell experiment viewer (SCEV) enables researchers to explore single-cell experiments in an interactive visual environment, overlaying curated cell metadata and gene expression patterns to reveal biologically meaningful cell states. By applying IPA’s embedding model of causal relationships, SCEV predicts upstream regulators and downstream functions that are likely active in specific cells or...
Scale up NGS bioinformatics analysis throughput with CLC Genomics server and... 25.05.2026 53:42
Explore how CLC Genomics Server enables the transition from ad hoc bioinformatics analyses to a scalable, centrally managed and production-ready infrastructure. We will show how the platform supports: - Secure and centralized compute environments - Controlled deployment of validated workflows - Multi-user access with governance and audit trails - Integration within existing IT and virtualized envi...
Beyond the Surface: Applying NGS to Advance Cosmetic R&D 20.05.2026 35:38
As cosmetic science advances, consumers are demanding products better tailored to their specific concerns. What if you could decode skin biology and translate it into targeted cosmetic innovation? Next-generation sequencing (NGS) is deepening our understanding of skin biology by enabling comprehensive, high-throughput analysis of DNA and RNA to identify key genetic and transcriptomic markers assoc...
T cell receptor repertoire analysis: Unraveling new strategies against cancer... 19.05.2026 44:02
Understanding the inner workings of the adaptive immune system is critical to new strategies for combatting cancer and infectious diseases. In this webinar led by Drs. Mazza, Mazzotti and de Souza, we will explore T-cell receptor (TCR) repertoire analysis from start to finish, examining the different steps, approaches and data analysis implications. Join us to gain a deeper understanding of the mo...
Accelerating hereditary variant interpretation: HGMD in Franklin 19.05.2026 38:15
“Reliable AI”? Sounds like a contradiction, but with HGMD in Franklin, it’s possible. By combining HGMD Pro’s comprehensive, expert-curated hereditary variant content and Franklin’s AI workflows and user-friendly interface, accelerated hereditary variant interpretation is now within closer reach. Whether you’re in diagnostics, research or bioinformatics, you will gain practical insights int...
Grazing for insights: Leveraging regulatory neutrophils toward bovine... 19.05.2026 34:46
Neutrophils, known for killing microbes, can be both beneficial and harmful during a tuberculosis (TB) infection. While neutrophils kill the bacteria early on, they also contribute to chronic inflammation and lung tissue destruction. However, recent studies show that these roles are associated with different subsets of neutrophils: regulatory ones that display major histocompatibility complex (MHC...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.